Kiniksa Pharmaceuticals International logo

Kiniksa Pharmaceuticals International

KNSA | NASDAQ
Chart Builder DCF Calculator
$78.80
+$0.67 (+0.86%)
Sep 22, 2026, 10:49 AM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
165.6M 183.58M 107.95M 122.72M 122.47M 114.04M
Short-Term Investments
248.48M 60.05M 98.42M 67.89M 59.73M 209.44M
Long-Term Investments
n/a n/a n/a n/a n/a n/a
Other Long-Term Assets
11.31M 10.32M 827K 5.82M 8.72M 5.59M
Receivables
15.59M 41.72M 21.27M 20.32M 3.99M n/a
Inventory
54.9M 26.36M 31.12M 21.6M 3.68M n/a
Other Current Assets
42.61M 20.08M 17.54M 10.54M n/a 210K
Total Current Assets
527.18M 331.8M 276.3M 243.06M 196.45M 333.25M
Property-Plant & Equipment
11.75M 11.04M 12.67M 7.04M 8.38M 10.62M
Goodwill & Intangibles
15.25M 16.25M 17.25M 18.25M 19.25M n/a
Total Long-Term Assets
236.46M 248.75M 250.03M 216.61M 36.35M 16.22M
Total Assets
763.63M 580.55M 526.32M 459.67M 232.8M 349.46M
Account Payables
2.03M 2.04M 8.25M 7.9M 1.87M 503K
Deferred Revenue
31.81M n/a 307K n/a n/a n/a
Short-Term Debt
2.99M n/a n/a n/a n/a n/a
Other Current Liabilities
102.36M 33.12M 36.91M 16.97M 1.54M 7.74M
Total Current Liabilities
139.18M 100.62M 63.67M 47.07M 44.82M 31.85M
Long-Term Debt
n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
18.52M 1.82M 1.86M 1.84M 270K 805K
Total Long-Term Liabilities
56.84M 41.5M 23.82M 16.46M 2.94M 5.68M
Total Liabilities
196.03M 142.12M 87.48M 63.52M 47.76M 37.53M
Total Debt
9.5M 9.86M 12.26M 5.92M 6.05M 6.99M
Book Value
567.61M 438.44M 438.84M 396.15M 185.04M 311.94M
Book Value Per Share
7.19 6.14 6.10 5.63 2.70 5.04
Common Stock
21K 20K 20K 19K 18K 18K
Retained Earnings
-462.14M -521.14M -477.95M -492.03M -675.4M -517.47M
Comprehensive Income
-25K -163K 6K 44K -66K -34K
Shareholders Equity
567.61M 438.44M 438.84M 396.15M 185.04M 311.94M
Total Investments
248.48M 60.05M 98.42M 67.89M 59.73M 209.44M

© 2026 bestshares.com. All rights reserved.